| Ident. | Authors (with country if any) | Title |
|---|
| 000571 (2020) |
Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon Choe | Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry. |
| 000653 (2019) |
Lianne Kearsley-Fleet [Royaume-Uni] ; Sunil Sampath [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] | Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom. |
| 000695 (2019) |
Michitaro Hayakawa [Japon] ; Keisuke Izumi [Japon] ; Misako Higashida-Konishi [Japon] ; Mari Ushikubo [Japon] ; Masako Tsukamoto [Japon] ; Kumiko Akiya [Japon] ; Kazuhiro Araki [Japon] ; Hisaji Oshima [Japon] | Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review. |
| 000704 (2019) |
Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon] | Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study. |
| 000706 (2019) |
Martina Biggioggero [Oman] ; Chiara Crotti [Italie] ; Andrea Becciolini [Oman] ; Ennio Giulio Favalli [Oman] | Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection. |
| 000723 (2019) |
Fenglong Xie [Royaume-Uni] ; Huifeng Yun [Royaume-Uni] ; Emily B. Levitan [Royaume-Uni] ; Paul Muntner [Royaume-Uni] ; Jeffrey R. Curtis [Royaume-Uni] | Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients. |
| 000768 (2019) |
Kosuke Ebina [Japon] ; Akira Miyama [Japon] ; Hideki Tsuboi [Japon] ; Shoichi Kaneshiro [Japon] ; Masataka Nishikawa [Japon] ; Hajime Owaki [Japon] ; Shigeyoshi Tsuji [Japon] ; Makoto Hirao [Japon] ; Yuki Etani [Japon] ; Atsushi Goshima [Japon] ; Jun Hashimoto [Japon] ; Hideki Yoshikawa [Japon] | The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. |
| 000818 (2019) |
C. Turesson [Suède] ; O. Börjesson [Suède] ; K. Larsson [Suède] ; A J Mohammad [Suède] ; A. Knight [Suède] | Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis. |
| 000870 (2019) |
Ching-Tsai Lin [Taïwan] ; Wen-Nan Huang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Yi-Ming Chen [Taïwan] ; Der-Yuan Chen [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan] | Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis - A three-year study in Taiwan. |
| 000880 (2019) |
Ajinkya Pawar [États-Unis] ; Rishi J. Desai [États-Unis] ; Daniel H. Solomon [États-Unis] ; Adrian J. Santiago Ortiz [États-Unis] ; Sara Gale [États-Unis] ; Min Bao [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis] | Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. |
| 000881 (2019) |
Kathrine Lederballe Gr N [Oman] ; Elizabeth V. Arkema [Suède] ; Bente Glintborg [Danemark] ; Frank Mehnert [Danemark] ; Mikkel Stergaard [Danemark] ; Lene Dreyer [Danemark] ; Mette N Rgaard [Danemark] ; Niels Steen Krogh [Danemark] ; Johan Askling [Suède] ; Merete Lund Hetland [Danemark] | Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden. |
| 000888 (2019) |
Michael D. George ; Joshua F. Baker ; Kevin Winthrop [États-Unis] ; Evo Alemao ; Lang Chen ; Sean Connolly ; Jesse Y. Hsu ; Teresa A. Simon ; Qufei Wu ; Fenglong Xie ; Shuo Yang ; Jeffrey R. Curtis | Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study. |
| 000892 (2019) |
Kenji Oku [Japon] ; Tatsuya Atsumi [Japon] | Rheumatology practice in Japan: challenges and opportunities. |
| 000894 (2019) |
Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France] | Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. |
| 000899 (2019) |
Ryuki Sakaguchi [Japon] ; Keita Fujikawa [Japon] ; Momoko Okamoto [Japon] ; Emi Matsuo [Japon] ; Kohei Matsumoto [Japon] ; Tomohisa Uchida [Japon] ; Kawashiri Shin-Ya [Japon] ; Masahiro Nakashima [Japon] ; Akinari Mizokami [Japon] ; Atsushi Kawakami [Japon] | Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder |
| 000902 (2019) |
Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon] | Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study. |
| 000930 (2019) |
Durga Prasanna Misra [Inde] ; Anupam Wakhlu [Inde] ; Vikas Agarwal [Inde] ; Debashish Danda [Inde] | Recent advances in the management of Takayasu arteritis. |
| 000950 (2019) |
Kenan Barut [Turquie] ; Amra Adrovic [Turquie] ; Sezgin Sahin [Turquie] ; Gurkan Tarcin [Turquie] ; Gulberk Tahaoglu [Turquie] ; Oya Koker [Turquie] ; Mehmet Yildiz [Turquie] ; Ozgur Kasapcopur [Turquie] | Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience. |
| 000B11 (2019) |
Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] ; Reiji Yamakawa [Japon] | Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study. |
| 000B13 (2019) |
Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France] | Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. |
| 000B44 (2019) |
Navita L. Mallalieu [États-Unis] ; Sunethra Wimalasundera [Royaume-Uni] ; Joy C. Hsu [États-Unis] ; Wendy Douglass [Royaume-Uni] ; Chris Wells [Royaume-Uni] ; Inmaculada Calvo Penades [Espagne] ; Ruben Cuttica [Argentine] ; Hans-Iko Huppertz [Allemagne] ; Rik Joos [Belgique] ; Yukiko Kimura [États-Unis] ; Diana Milojevic [États-Unis] ; Margalit Rosenkranz [États-Unis] ; Kenneth Schikler [États-Unis] ; Tamas Constantin [Hongrie] ; Carine Wouters [Belgique] | Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial |
| 000B83 (2019) |
Toshiyuki Watanabe [Japon] ; Jun Fukae [Japon] ; Shinji Fukaya [Japon] ; Norifumi Sawamukai [Japon] ; Masato Isobe [Japon] ; Megumi Matsuhashi [Japon] ; Masato Shimizu [Japon] ; Kazumasa Akikawa [Japon] ; Kazuhide Tanimura [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] | Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs. |
| 000C23 (2019) |
Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Kazuyuki Yoshizaki [Japon] | IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. |
| 000C93 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses |
| 000D20 (2019) |
Han Joo Baek [Corée du Sud] ; Mie Jin Lim [Corée du Sud] ; Won Park [Corée du Sud] ; Sung Hwan Park [Corée du Sud] ; Seung-Cheol Shim [Corée du Sud] ; Dae-Hyun Yoo [Corée du Sud] ; Hyun Ah Kim [Corée du Sud] ; Soo Kon Lee [Corée du Sud] ; Yun Jong Lee [Corée du Sud] ; Young Eun Park [Corée du Sud] ; Hoon-Suk Cha [Corée du Sud] ; Yeong-Wook Song [Corée du Sud] | Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis. |
| 000D47 (2019) |
Izumi Kurata [Japon] ; Hiroto Tsuboi [Japon] ; Mayu Terasaki [Japon] ; Masaru Shimizu [Japon] ; Hirofumi Toko [Japon] ; Fumika Honda [Japon] ; Ayako Ohyama [Japon] ; Mizuki Yagishita [Japon] ; Atsumu Osada [Japon] ; Hiroshi Ebe [Japon] ; Hoshimi Kawaguchi [Japon] ; Hiroyuki Takahashi [Japon] ; Shinya Hagiwara [Japon] ; Hiromitsu Asashima [Japon] ; Yuya Kondo [Japon] ; Isao Matsumoto [Japon] ; Takayuki Sumida [Japon] | Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis. |
| 000D54 (2019) |
Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon] | Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study- |
| 000E39 (2019) |
C. Diener [Allemagne] ; G. Horneff [Allemagne] | Comparison of adverse events of biologicals for treatment of juvenile idiopathic arthritis: a systematic review. |
| 000E42 (2019) |
Katsuhiko Takabayashi [Japon] ; Fumihiko Ando [États-Unis] ; Takahiro Suzuki [Japon] | Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data. |
| 000E47 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
| 001089 (2018) |
Chia-Hua Lin [Taïwan] ; Hsiang-Cheng Chen [Taïwan] ; Hong-Wei Gao [Taïwan] ; Bai-Yao Wu [Taïwan] | Wolf's post-herpetic isotopic response to tocilizumab for rheumatoid arthritis. |
| 001119 (2018) |
Hitoshi Imamura [Japon] ; Shigeki Momohara [Japon] ; Koichiro Yano [Japon] ; Yu Sakuma [Japon] ; Masanori Nakayama [Japon] ; Haruki Tobimatsu [Japon] ; Katsunori Ikari [Japon] | Tocilizumab treatment in patients with rheumatoid arthritis is associated with reduced fibrinogen levels and increased blood loss after total knee arthroplasty. |
| 001141 (2018) |
Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon] | Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). |
| 001150 (2018) |
Maria Gerosa [Italie] ; Lorenza Maria Argolini [Italie] ; Carolina Artusi [Italie] ; Cecilia Beatrice Chighizola [Italie] | The use of biologics and small molecules in pregnant patients with rheumatic diseases. |
| 001205 (2018) |
Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France] | Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data. |
| 001206 (2018) |
Andrew I. Rutherford [Royaume-Uni] ; Sujith Subesinghe [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] ; James B. Galloway [Royaume-Uni] | Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. |
| 001212 (2018) |
Sung Soo Ahn [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jason Jungsik Song [Corée du Sud] ; Yong Beom Park [Corée du Sud] ; Jun Yong Park [Corée du Sud] ; Sang Won Lee [Corée du Sud] | Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience. |
| 001213 (2018) |
Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon] | Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting. |
| 001216 (2018) |
Sen Wang [République populaire de Chine] ; Qian He [République populaire de Chine] ; Zongwen Shuai [République populaire de Chine] | Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. |
| 001218 (2018) |
I. Serio [Italie] ; F. Tovoli [Italie] | Rheumatoid arthritis: new monoclonal antibodies. |
| 001222 (2018) |
Jacqueline Bullock [États-Unis] ; Syed A A. Rizvi [États-Unis] ; Ayman M. Saleh [Oman] ; Sultan S. Ahmed [États-Unis] ; Duc P. Do [États-Unis] ; Rais A. Ansari [États-Unis] ; Jasmin Ahmed [États-Unis] | Rheumatoid Arthritis: A Brief Overview of the Treatment. |
| 001235 (2018) |
F. Iannone [Italie] ; G. Ferraccioli [Italie] ; L. Sinigaglia [Italie] ; E G Favalli [Italie] ; P. Sarzi-Puttini [Italie] ; F. Atzeni [Italie] ; R. Gorla [Italie] ; C. Bazzani [Italie] ; M. Govoni [Italie] ; I. Farina [Italie] ; E. Gremese [Italie] ; A. Carletto [Italie] ; A. Giollo [Italie] ; M. Galeazzi [Italie] ; R. Foti [Italie] ; L. Bianchino [Italie] ; L. La Grasta [Italie] ; G. Lapadula [Italie] | Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA. |
| 001247 (2018) |
Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon] | Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database. |
| 001254 (2018) |
Eva-Maria Didden [Suisse] ; Yann Ruffieux [Suisse] ; Noemi Hummel [Suisse] ; Orestis Efthimiou [Suisse] ; Stephan Reichenbach [Suisse] ; Sandro Gsteiger [Suisse] ; Axel Finckh [Suisse] ; Christine Fletcher [Royaume-Uni] ; Georgia Salanti [Suisse] ; Matthias Egger [Suisse] | Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis. |
| 001260 (2018) |
Surabhi S. Vinod [États-Unis] ; Annelle B. Reed [États-Unis] ; Jamelle Maxwell [États-Unis] ; Randy Q. Cron [États-Unis] ; Matthew L. Stoll [États-Unis] | Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year. |
| 001264 (2018) |
Thomas Frisell [Suède] ; Eva Baecklund [Suède] ; Karin Bengtsson [Suède] ; Daniela Di Giuseppe [Suède] ; Helena Forsblad-D'Elia [Suède] ; Johan Askling [Suède] | Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics. |
| 001277 (2018) |
Seoyoung C. Kim [États-Unis] ; Daniel H. Solomon [États-Unis] ; James R. Rogers [États-Unis] ; Sara Gale [États-Unis] ; Micki Klearman [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis] | No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study. |
| 001278 (2018) |
Rodrigo Ayres De Oliveira [Brésil] ; Iolanda M. Fierro [Brésil] | New strategies for patenting biological medicines used in rheumatoid arthritis treatment. |
| 001299 (2018) |
Violetta Opoka-Winiarska [Pologne] ; Zbigniew Uber [Pologne] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Irina Nikishina [Russie] ; Gra Yna D Bowska [Pologne] ; El Bieta Smolewska [Pologne] | Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial. |
| 001303 (2018) |
Fabio Cacciapaglia [Italie] ; Maria Grazia Anelli [Italie] ; Angela Rinaldi [Italie] ; Marco Fornaro [Italie] ; Giuseppe Lopalco [Italie] ; Crescenzio Scioscia [Italie] ; Giovanni Lapadula [Italie] ; Florenzo Iannone [Italie] | Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment. |
| 001335 (2018) |
Kazuha Kizaki [Japon] ; Fumiharu Yamashita [Japon] ; Tomoya Hayashi [Japon] ; Noboru Funakoshi [Japon] | Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. |
